Moneycontrol PRO
Outskill Genai
HomeNewsBusinessFrom struggling to meet domestic demand, to exporting, India's PPE manufacturing tale is one of self-reliance

From struggling to meet domestic demand, to exporting, India's PPE manufacturing tale is one of self-reliance

In April, PPE suits that were required by health workers to tackle the COVID-19 outbreak, were found to be in an acute short supply. Following this, India ramped up production of protective gears and medical equipment, and reducing dependency on foreign countries for these items

July 01, 2020 / 17:47 IST

On June 29, Union Minister Piyush Goyal said the Centre has allowed monthly export of 50 lakh medical overalls from personal protection equipment (PPE) suits. He claimed this move will help boost the ‘Make in India’ initiative envisioned by Prime Minister Narendra Modi.

The product was banned for export earlier, but it has now been moved to the restricted category.

When the COVID-19 pandemic broke out in India on January 30, the Ministry of Home Affairs (MHA) had constituted an empowered group consisting of officials from the textiles ministry and Defence Research and Development Organisation (DRDO), the Department of Pharmaceuticals, and Department for Promotion of Industry and Internal Trade to ensure the availability of essential medical equipment.

In April, PPE suits that were required by health workers to tackle the COVID-19 outbreak were found to be in an acute short supply. Following this, India ramped up production of COVID-19 protective gears and medical equipment, and reduced dependency on foreign countries for these items.

In May, the Centre ordered for 2.22 crore PPE kits, of which around 1.42 crore was bought from domestic manufacturers and the rest imported. "Earlier, there was no domestic manufacturing of PPE in the country and almost all of them were imported. Now, we have 111 indigenous manufacturers. PPE production capacity has increased so much that it has become a Rs 7,000-crore industry in India, the biggest after China," PD Vaghela, Chairman of one of the 11 empowered groups constituted for planning and ensuring implementation in response to the disease outbreak, said.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

A little over 3,000 PPEs were being churned out in a day from March 30 onwards. Now, over 1,100 firms in the country manufacture about 700,000-800,000 PPE daily. Over 250 licenced sellers are registered on the government’s e-marketplace (GeM) portal to cater to the extra demand by states.

The outbreak of the virus, its consequent economic damage and the recent standoff with China at the Ladakh border have put into sharp focus India bilateral trade with its eastern neighbour. Due to India's import dependency in some sectors on China, Prime Minister Narendra Modi too has raised concerns.

China is one of India’s leading trade partners and constitutes 9 percent of India’s total exports and 18 percent of total merchandise imports.

Import dependency on China for a range of raw materials (APIs, basic chemicals, agro-intermediates) and critical components (auto, durables, capital goods) is skewed. Of the respective imports, 20 percent of the auto components and 70 percent of electronic components come from China. Similarly, 45 percent of consumer durables, 70 percent of APIs and 40 percent of leather goods imported are from China.

“PPE manufacturers showed extraordinary enterprise and nimbleness in its ability to rejig large production facilities to manufacture PPEs. A single mask manufacturing machine can produce one lakh pieces per day and we have more than 200 such machines currently. The government should soon extend the export opportunity to N95 masks as well,” Dr Sakthivel, Chairman, Apparel Export Promotion Council, said.

The size of the global market for PPEs would be more than $60 billion over the next five years and India is competing with countries like Bangladesh, Indonesia and Pakistan as they too have lifted the ban on PPE exports and are receiving huge orders from large buyers in the US and Europe, Sakthivel said.

Kamalika Ghosh
first published: Jul 1, 2020 05:47 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347